| abstract |
The invention provides compositions and methods for treating diseases such as cancer. The invention also relates to methods of making improved CART cell therapies, e.g., with increased level, expression, and/or activity of a TOX family protein, e.g., a TOX2 protein. The invention further provides TOX2 protein and TOX2 modulators, and methods of use of the same in connection with CART cells. |